Abstract
BackgroundIt is generally stated that oral antiviral therapy in patients with chronic hepatitis B (CHB) decreases the risk of developing hepatocellular carcinoma (HCC). Although oral nucleos(t)ide analogues (NUCs) may induce...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have